ArticleAllergy2026

Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.

Ayano Fukushima-Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.